Unlock regulatory insights with Watson. Learn More

Draft Guidance for Industry on Distributing Scientific and Medical Publications on Risk Information For Approved Prescription Drugs and Biological Products--Recommended Practices; Availability

Center CDER
VIEW ALL (2)Primary Documents